Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors.

Li, Weiping

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. [electronic resource] - Journal of hematology & oncology 07 2019 - 73 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1756-8722

10.1186/s13045-019-0761-2 doi


Cell Line, Tumor
Cell Proliferation
Cell Survival
Female
Humans
Lymphoma, Large B-Cell, Diffuse--genetics
Male
Proto-Oncogene Proteins c-bcl-2--metabolism
Proto-Oncogene Proteins c-bcl-6--metabolism
Proto-Oncogene Proteins c-myc--metabolism
Transfection